BRIC Third Foundation Day and India Bioeconomy Growth
Source:PIB ↗

Why It Matters
Understanding the consolidation and performance of autonomous research councils like BRIC is crucial for assessing India's progress in biotechnology, bio-manufacturing, and translation of research into commercial products.
Summary
The Biotechnology Research and Innovation Council (BRIC) recently celebrated its third Foundation Day at the National Institute of Immunology (NII) in New Delhi. The event brought together key policymakers, scientists, and industry leaders to review the progress of BRIC institutions operating under the Department of Biotechnology (DBT). Discussions centered on expanding India's bioeconomy, boosting indigenous medical R&D, strengthening vaccine and therapeutic manufacturing through public-private partnerships, and fostering deep-tech start-ups to support national development goals.
Key Points
- The Biotechnology Research and Innovation Council (BRIC) celebrated its third Foundation Day in New Delhi, highlighting achievements in translational biotechnology and bioeconomy.
- BRIC brings together several premier autonomous research institutions under the Department of Biotechnology (DBT) to foster synergy, deep science research, and commercialization.
- The event emphasized the critical role of institutions like the National Institute of Immunology (NII) and BIRAC in driving start-ups, vaccine development, and therapeutics.
- Discussions focused on leveraging biotechnology for healthcare resilience, agriculture innovation, and sustainable bio-manufacturing under the Vikshit Bharat vision.
Prelims Trap
BRIC celebrated its third Foundation Day...
Aspirants often confuse BRIC (Biotechnology Research and Innovation Council) with international groupings like BRICS or international financial institutions.
Static Concepts Connected
What is the administrative structure and mandate of the Biotechnology Research and Innovation Council (BRIC)?
- Parent Ministry: Apex body operating under the Department of Biotechnology (DBT), Ministry of Science and Technology.
- Core Objective: Consolidates several autonomous biotechnology institutes to unify governance, optimize resources, and boost translational R&D.
- Vision 2047: Aims to scale India's bioeconomy and accelerate commercialization of indigenous deep-tech start-ups.
Cross-Topic Patterns
Bioeconomy + Industrial Policy Linkage
India's bioeconomy targets tie directly into industrial policy and Atmanirbhar Bharat, shifting focus from IT services to high-value bio-manufacturing and deep-tech.
BRIC's consolidation under DBT and its role in bio-manufacturing will likely feature in matching or multi-statement S&T policy questions.
Linked PYQs · 3
Linked PYQs · 3
- 2025MainsGS3
How can India achieve energy independence through clean technology by 2047? How can biotechnology can play a crucial role in this endeavour?
- 2026PrelimsGS1
Which of the following statements with regard to GenomeIndia Project is/are correct ? 1. It is a part of the Human Genome Project. 2. The project is funded by the Department of Biotechnology (DBT), Government of India. 3. Its primary aim is to build a catalogue of genetic diversity of the Indian population. Select the answer using the code given below :
- 2021MainsGS3
What are the research and developmental achievements in applied biotechnology? How will these achievements help to uplift the poorer sections of the society?